Alternatively spliced tissue factor identified as promising new biomarker for aggressive cancers

October 26, 2009,

A recently discovered form of the protein that triggers blood clotting may play a key role in the molecular mechanisms leading to the growth of certain metastatic cancers, according to new research reported by an international team of scientists.

The protein, called "Tissue Factor," is present in various tissues, but is most prominent in vascular structures such as blood vessels. Previous studies have shown that alternatively spliced Tissue Factor (asTF) contributes to cancer growth, but the molecular events leading to this were previously unknown.

In a preclinical study, an international team of collaborators including Vladimir Bogdanov, PhD, of the University of Cincinnati (UC), and Henri Versteeg, PhD, of the Einthoven Laboratory of Experimental Vascular Medicine at Leiden University Medical Center in the Netherlands, has described in detail how asTF works to contribute to cancerous cell growth.

They report their findings in an early edition of Proceedings of National Academy of Sciences (PNAS). This is the first study to report the specific mechanisms of action that lead to increased angiogenesis when alternatively spliced Tissue Factor is present.

"This is an important breakthrough in cancer research because we are able to draw a more complete molecular picture of how Tissue Factor contributes to cancer growth," says Bogdanov, who discovered asTF while a postdoctoral fellow and is currently the director of the newly established hemostasis research program at the UC College of Medicine. "This will help translate basic research into real-life for therapies targeted to stop angiogenesis."

Angiogenesis is the process by which tumors grow vessels to fuel their growth and ability to reach out and metastasize to other tissues.

Originally, researchers believed that this shorter Tissue Factor acts similarly to the well known "full length" Tissue Factor. What they discovered actually occurred, however, was asTF binding to the surface molecules called integrins on endothelial cells to induce signaling cascades triggering angiogenesis.

This resulted in increased cell adhesion, cell migration and development of new vessels in both cellular and animal models. High levels of asTF were also found in specimens of human cervical cancer.

"When we started this research, we expected that asTF would influence cancerous growth in a manner similar to full length Tissue Factor, namely the activation of blood clotting," says Versteeg. "The clotting of blood activates the so-called protease activated receptors on cell surfaces and these receptors have been thought to be the bad guys in tumor growth. That asTF does not influence tumor growth through blood clotting was a completely unexpected finding. How exactly asTF activates integrins, and in which types of cancer, remains to be uncovered and should keep us busy for some time."

"Our findings introduce a whole new way of studying how the Tissue Factor gene influences tissue formation process, including ," explains Bogdanov. "This is another level of understanding the molecular actions behind Tissue Factor."

Expression of the Tissue Factor gene is increased in many forms of cancer. Researchers hope their findings will help guide development of new ways of targeting specific forms of Tissue Factor to stop cancerous cell growth while producing minimal impact on the body's capability to stop bleeding.

Source: University of Cincinnati (news : web)

Related Stories

Recommended for you

Single blood test screens for eight cancer types

January 18, 2018
Johns Hopkins Kimmel Cancer Center researchers developed a single blood test that screens for eight common cancer types and helps identify the location of the cancer.

Researchers find a way to 'starve' cancer

January 18, 2018
Researchers at Vanderbilt University Medical Center (VUMC) have demonstrated for the first time that it is possible to starve a tumor and stop its growth with a newly discovered small compound that blocks uptake of the vital ...

How cancer metastasis happens: Researchers reveal a key mechanism

January 18, 2018
Cancer metastasis, the migration of cells from a primary tumor to form distant tumors in the body, can be triggered by a chronic leakage of DNA within tumor cells, according to a team led by Weill Cornell Medicine and Memorial ...

Modular gene enhancer promotes leukemia and regulates effectiveness of chemotherapy

January 18, 2018
Every day, billions of new blood cells are generated in the bone marrow. The gene Myc is known to play an important role in this process, and is also known to play a role in cancer. Scientists from the German Cancer Research ...

These foods may up your odds for colon cancer

January 18, 2018
(HealthDay)—Chowing down on red meat, white bread and sugar-laden drinks might increase your long-term risk of colon cancer, a new study suggests.

The pill lowers ovarian cancer risk, even for smokers

January 18, 2018
(HealthDay)—It's known that use of the birth control pill is tied to lower odds for ovarian cancer, but new research shows the benefit extends to smokers or women who are obese.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.